Discover how Avitia's advanced molecular diagnostics platform empowers labs and clinicians with rapid, accurate cancer mutation identification, enabling personalized treatments and improving patient outcomes.
Total raised: $5M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 27.02.2025 | Seed | $5M | - |
Mentions in press and media 2
| Date | Title | Description |
| 27.02.2025 | Avitia Raises $5M in Seed Funding | Avitia, a Montreal, Canada-based AI company providing end-to-end testing solutions to rapidly identify cancer mutations and applicable treatments, raised $5M in seed funding. PacBridge Capital Partners made the investment. The company inten... |
| - | Avitia | “Discover how Avitia's advanced molecular diagnostics platform empowers labs and clinicians with rapid, accurate cancer mutation identification, enabling personalized treatments and improving patient outcomes.” |